Topiramate
- Product NDC
- 0615-7563
- 11-digit product format
- 006157563
- Labeler code
- 0615
- Product ID
- 0615-7563_d8d1e518-2b20-4a4b-bd1d-f13c9f762d7a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Topiramate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA078235
- Marketing category
- ANDA
- Marketing start
- 2009-03-27
- Marketing end
- 0000-00-00
- Substance
- TOPIRAMATE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0615-7563 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 0615-7563 | 0615-7563-05 | D | Discontinued by firm | 2026-08-03 | |
| excluded package | package | 0615-7563 | 0615-7563-39 | D | Discontinued by firm | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078235-001 | TOPIRAMATE | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078235-002 | TOPIRAMATE | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078235-003 | TOPIRAMATE | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078235-004 | TOPIRAMATE | TOPIRAMATE | 200MG | TABLET / ORAL | AB | 2009-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078235-001 | AB |
| A078235-002 | AB |
| A078235-003 | AB |
| A078235-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078235-001 | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078235-002 | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078235-003 | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078235-004 | TOPIRAMATE | 200MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078235-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078235-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078235-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078235-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 7e0834ee-920b-496f-954d-f9d81c3ba2d6 | 2026-07-17 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 0366164b-1846-443d-9564-dbe52d8d9b65 | 2026-07-08 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | St. Mary's Medical Park Pharmacy | 92637f92-9d7c-c246-e053-2995a90a0347 | 2026-06-26 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | St. Mary's Medical Park Pharmacy | 9221403c-467f-738e-e053-2995a90ac8fd | 2026-06-26 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Bryant Ranch Prepack | 8abe45eb-cc75-4625-ae3d-5b2a038c4907 | 2026-06-24 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Bryant Ranch Prepack | bffcd213-4f09-4a5b-8ccb-591a68be402b | 2026-06-24 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Bryant Ranch Prepack | 57462baf-2f32-4bde-9627-2214c8af9370 | 2026-06-24 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Bryant Ranch Prepack | ca9ce6c1-5a60-467a-9ad5-acc7a9f8ca15 | 2026-06-24 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Coupler LLC | 5461f33d-eaef-dce3-e063-6294a90aeff8 | 2026-06-16 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | AvPAK | 53c3f980-f05b-c671-e063-6294a90a77d5 | 2026-06-09 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 6f461f84-bfad-44fa-a2bd-5ea1566444b5 | 2026-05-21 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | b7539f52-06e9-4663-b401-92f5f83653cc | 2026-05-21 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 5ce65b7f-9215-47a8-a784-f87a810bd7e4 | 2026-05-19 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 2f5b1b0b-fd8a-4c4e-a85a-519ca841a0db | 2026-05-19 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 149d20de-f262-4567-aa97-d4d28a1653cb | 2026-04-30 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Quallent Pharmaceuticals Health LLC | 9dae6824-6913-42de-b98a-cdcb0d3b4a46 | 2026-04-25 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | 67dcdd6e-48bc-418e-a887-805929d83ce0 | 2026-04-15 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | afd4c2b9-b80c-b43a-e053-2995a90ac923 | 2026-01-01 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | f3321dc5-0fb7-0d12-e053-2a95a90a9694 | 2026-01-01 | Warnings, Adverse reactions | 078235 ANDA078235 |
| topiramate | TOPIRAMATE | Northwind Health Company, LLC | ffd7be08-050e-dfcb-e053-6394a90ad286 | 2026-01-01 | Warnings, Adverse reactions | 078235 ANDA078235 |